----item----
version: 1
id: {87A06BFB-9E44-45C5-A3F1-4E95BD8D6053}
database: master
path: /sitecore/content/Pharma/ScripIntelligence/Home/Policy and Regulation/Policy
parent: {A72E96A9-B2EC-4D40-818B-6EB54832A79A}
name: Policy
master: {00000000-0000-0000-0000-000000000000}
template: {77604558-3056-497B-93D8-E53BC5619DDB}
templatekey: Topic Page

----version----
language: en
version: 1
revision: ca10929f-c927-4c3b-8256-ce6227af33f1

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 6

Policy
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 10

Topic Page
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 10

Topic Page
----field----
field: {04BF00DB-F5FB-41F7-8AB7-22408372A981}
name: __Final Renderings
key: __final renderings
content-length: 1976

<r xmlns:p="p" xmlns:s="s" p:p="1"><d id="{FE5D7FDF-89C0-4D99-9AA3-B5FBD009C9F3}"><r uid="{522F9833-8000-4468-899E-48A00F9C58DB}" p:before="r[@uid='{A99E3B4A-AACC-40B1-9476-7C4B3CE477FF}']" s:id="{1AA9B776-B2D0-4B04-B118-CE22D1263656}" s:ph="main-content" /><r uid="{A99E3B4A-AACC-40B1-9476-7C4B3CE477FF}" p:before="r[@uid='{5A6963F9-8575-4C79-A176-F8B76F843EC7}']" s:ds="{0815DBCE-5F64-4609-8852-53253DBE838F}" s:id="{8C64BF41-EFAF-4867-A5A1-91EEB97F2985}" s:ph="/main-content/right-curated-content_a5b707da-9255-4402-9f31-aca2100c48d7" /><r uid="{5A6963F9-8575-4C79-A176-F8B76F843EC7}" p:before="r[@uid='{7FDA0E57-A7EA-4A7B-A5B0-983BB36729B1}']" s:ds="{DC315C68-943D-4F27-99C8-CCEB2C4DBCC0}" s:id="{A94F54D2-AD2B-4921-82B3-5093C020674C}" s:par="Show Image" s:ph="/main-content/left-curated-content_a5b707da-9255-4402-9f31-aca2100c48d7" /><r uid="{7FDA0E57-A7EA-4A7B-A5B0-983BB36729B1}" p:before="r[@uid='{A5B707DA-9255-4402-9F31-ACA2100C48D7}']" s:ds="{D00CE8ED-0D11-45BE-ABFF-987358334F55}" s:id="{A94F54D2-AD2B-4921-82B3-5093C020674C}" s:par="Show Image=1" s:ph="/main-content/left-curated-content_a5b707da-9255-4402-9f31-aca2100c48d7" /><r uid="{A5B707DA-9255-4402-9F31-ACA2100C48D7}" p:before="r[@uid='{2A20F8F4-8384-4DB2-B430-416F9FE51AE1}']" s:id="{3EFF8328-17E2-41E9-BBCB-E4361A60D5C9}" s:ph="main-content" /><r uid="{2A20F8F4-8384-4DB2-B430-416F9FE51AE1}" p:before="r[@uid='{0F6A6227-C265-4521-8F6D-FA78653AE581}']" s:ds="" s:id="{17FDDCB4-4745-4113-9DF9-D003DD6231E9}" s:par="Display Title=1&amp;Number To Display={9AF30384-21C4-4341-A825-190E44F87A7E}&amp;Subjects={C547E0DE-05E0-4671-8C7A-37F0D3DF4F0E}" s:ph="/main-content/two-column-curated_9857ddc4-452f-4cce-9f24-71727b23fb99" /><r uid="{0F6A6227-C265-4521-8F6D-FA78653AE581}" p:before="r[@uid='{9857DDC4-452F-4CCE-9F24-71727B23FB99}']" /><r uid="{9857DDC4-452F-4CCE-9F24-71727B23FB99}" s:ds="{526786FB-5942-4D7A-A129-7BD74ED4D738}" s:id="{FEFB319E-28B6-4BE9-B2F2-655329858135}" s:ph="main-content" /></d></r>
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160424T032457Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 15

sitecore\deweyd
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

ca10929f-c927-4c3b-8256-ce6227af33f1
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160516T201434Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 16

sitecore\youngdo
----field----
field: {001DD393-96C5-490B-924A-B0F25CD9EFD8}
name: __Lock
key: __lock
content-length: 5

<r />
